Progression-free survival
Showing 26 - 50 of >10,000
Colorectal Cancer, Chemotherapeutic Toxicity, Survivorship Trial in Nijmegen, Utrecht (Continuous aerobic and resistance
Recruiting
- Colorectal Cancer
- +3 more
- Continuous aerobic and resistance exercise intervention
- Continuous aerobic and aerobic interval exercise intervention
-
Almere, Netherlands
- +11 more
Oct 25, 2022
Recurrent Cervical Carcinoma, Radiotherapy, Epidermal Growth Factor Receptor Trial in Beijing (Combination of nimotuzumab and
Recruiting
- Recurrent Cervical Carcinoma
- +6 more
- Combination of nimotuzumab and radiotherapy
-
Beijing, Beijing, ChinaLei Li
Dec 18, 2020
Follicular Lymphoma, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma Trial in United States (dietary supplement, biological,
Active, not recruiting
- Follicular Lymphoma
- +3 more
- Vitamin D
- +2 more
-
Miami, Florida
- +6 more
Mar 6, 2022
Prognostic Factors Affecting Recurrence and Disease-Free
Recruiting
- Rectal Cancer
- curative surgery for cancer rectum
-
Qinā, EgyptQena Faculty of Medicine, South Valley University Hospitals
Oct 21, 2023
Renal Cell Carcinoma, Neoadjuvant Trial (Axitinib plus Toripalimab, radical nephrectomy)
Not yet recruiting
- Renal Cell Carcinoma
- Neoadjuvant
- Axitinib plus Toripalimab
- radical nephrectomy
- (no location specified)
Feb 12, 2023
Survival Analysis in Children and Adults Adrenocortical Cancer
Active, not recruiting
- Adrenocortical Carcinoma
-
Bethesda, MarylandNational Cancer Institute (NCI)
Jan 20, 2023
Crestal Bone Loss, Survival Rate Trial in Cairo (placement of dental implants)
Completed
- Crestal Bone Loss
- Survival Rate
- placement of dental implants
-
Cairo, EgyptAin Shams University
Oct 21, 2023
Improving Liver Transplant-free Survival in Acute Decompensation
Not yet recruiting
- Decompensated Cirrhosis
- No intervention
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Jul 12, 2023
Metastatic Cancer Trial in Besançon, Montbéliard (Additional biological samples)
Recruiting
- Metastatic Cancer
- Additional biological samples
-
Besançon, France
- +1 more
May 10, 2022
Severe Toxicity Free Survival Following Childhood Acute
Recruiting
- Acute Lymphoblastic Leukemia
-
Copenhagen, DenmarkKjeld Schmiegelow
Dec 9, 2022
Disease-free Survival of High-risk Head-neck Cutaneous Squamous
Active, not recruiting
- Carcinoma, Squamous Cell
- +5 more
- Treatment
-
Maastricht, Netherlands
- +1 more
Apr 26, 2023
Prostate Cancer, Node; Prostate, Radiotherapy Side Effect Trial in Quebec (Report and compare changes in a non-inferiority
Recruiting
- Prostate Cancer
- +2 more
- Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS)
- +7 more
-
Quebec, CanadaCHUdeQuebec
Apr 7, 2023
Disease Free Survival, Overall Survival, Pancreatic Cancer Trial in Milan (use of targeted drugs such as aspirin, B-Blockers,
Recruiting
- Disease Free Survival
- +2 more
- use of targeted drugs such as aspirin, B-Blockers, Metformin, ACE-inhibitors, Statins
-
Milan, ItalyIRCCS San Raffaele
Mar 7, 2022
Textbook Outcome in Colon Carcinoma
Completed
- Outcome Assessment
- Cancer of Colon
- Colon oncological resection
-
Alicante, SpainHospital General Universitario Dr. Balmis
Jan 5, 2023
Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)
Terminated
- Breast Neoplasms
- Doxorubicin
- +7 more
-
Saint Louis, MissouriWashington University School of Medicine
Oct 31, 2022
Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery
Recruiting
- Prostate Cancer
- +6 more
- Radiotherapy (SBRT) and/or surgery (metastasectomy)
- +2 more
-
Leuven, BelgiumUniversity Hospitals Leuven
Jun 7, 2022
to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally
Recruiting
- to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
- Capecitabine 500Mg Oral Tablet
-
Shanghai, ChinaEye & ENT Hospital, Fudan University
Jul 2, 2023
Progression-free Survival, Overall Survival, Toxicity Trial in Beijing (pegylated liposomal doxorubicin, pirarubicin)
Withdrawn
- Progression-free Survival
- +2 more
- pegylated liposomal doxorubicin
- pirarubicin
-
Beijing, ChinaPeking University People's Hospital
May 15, 2020
Metabolic Syndrome, Pregnant Women, Birth Outcomes Trial in Jimma (Exposure, Non exposure)
Recruiting
- Metabolic Syndrome
- +4 more
- Exposure
- Non exposure
-
Jimma, EthiopiaJimma University Medical Center
Jun 28, 2023
Survival in Adult MRD Positive Acute Lymphoblastic Leukemia
Completed
- Acute Lymphoblastic Leukemia
-
Brno, Czechia
- +9 more
Sep 12, 2022
Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence Trial (triptorelin, goserelin, leuprorelin)
Not yet recruiting
- Prostate Cancer
- +4 more
- triptorelin, goserelin, leuprorelin
- (no location specified)
Mar 10, 2023
Non-Squamous NSCLC Trial in Worldwide (Placebo, RG1507, erlotinib [Tarceva])
Terminated
- Non-Squamous Non-Small Cell Lung Cancer
- Placebo
- +2 more
-
Beverly Hills, California
- +56 more
Dec 5, 2020
Pancreatic Adenocarcinoma Trial in Philadelphia (Niraparib + Nivolumab, Niraparib + Ipilimumab)
Active, not recruiting
- Pancreatic Adenocarcinoma
- Niraparib + Nivolumab
- Niraparib + Ipilimumab
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania, Abramson Cancer Center
Mar 23, 2022
Contrast-enhanced CT-based Deep Learning Model for Preoperative
Recruiting
- Predictive Ability of Contrast-enhanced CT-based Deep Learning Model in Patients With Localised ccRCC
- +2 more
-
Chongqing, Chongqing, ChinaYingjie Xv
Oct 12, 2023